AstraZeneca adds fourth trial: Phase 3 AZD6234 in obesity, adjunct to incretinsAug 21Weekly roundup, 4 itemsAstraZenecaAZD0292
Olaparib Phase 2 results posted; three diabetes labels updated; new myeloma CAR-T trial recruitsAug 14Weekly roundup, 9 itemsAstraZenecaAZD0120
AstraZeneca registers Phase III bladder cancer trial; joins Natera-led breast cancer studyJul 23Weekly roundup, 5 itemsAstraZenecaAZD6489
Sign inSign in